Skip to main content
. 2019 Jun 26;23(8):5165–5175. doi: 10.1111/jcmm.14385

Figure 8.

Figure 8

The expression of miR‐629, FOXO3 and PERP mRNA in clinical samples. A, The expression of miR‐629 in the plasma from healthy controls (n = 14) and PAH patients (n = 14) was determined by qRT‐PCR. B, The expression of FOXO3 mRNA in the plasma from healthy controls (n = 14) and PAH patients (n = 14) was determined by qRT‐PCR. C, The expression of PERP mRNA in the plasma from healthy controls (n = 14) and PAH patients (n = 14) was determined by qRT‐PCR. *P < 0.05 and **P < 0.01 versus control groups